Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Astrocyte Ablation Induced by La-Aminoadipate (L-Aaa) Potentiates Remyelination in a Cuprizone Demyelinating Mouse Model Publisher Pubmed



Madadi S1 ; Pasbakhsh P1 ; Tahmasebi F1 ; Mortezaee K2 ; Khanehzad M1 ; Boroujeni FB1 ; Noorzehi G3 ; Kashani IR1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Poursina Street, Tehran, Iran
  2. 2. Department of Anatomy, School of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran
  3. 3. Laboratory Technology Faculty, Khatam Al-Nabieen University, Kabul, Afghanistan

Source: Metabolic Brain Disease Published:2019


Abstract

Chronic demyelination in the central nervous system (CNS) is accompanied by an increase in the number of reactive astrocytes and astrogliosis. There are controversial issues regarding astrocytes and their roles in demyelinating diseases in particular for multiple sclerosis (MS). We aimed to evaluate possible roles for pharmacologic astrocyte ablation strategy using La-aminoadipate (L-AAA) on remyelination in a cuprizone model of demyelination. Male C57BL/6 mice were fed with 0.2% cuprizone for 12 weeks followed by 2-week administration of L-AAA through a cannula inserted 1 mm above the corpus callosum. Rotarod test showed a significant decrease in the range of motor coordination deficits after ablation of astrocytes in mice receiving cuprizone. Results of Luxol fast blue (LFB) and transmission electron microscopy (TEM) for evaluation of myelin content within the corpus callosum revealed a noticeable rise in the percentage of myelinated areas and in the number of myelinated fibers after L-AAA administration in the animals. Astrocyte ablation reduced protein expressions for GFAP (an astrocyte marker) and Iba-1 (a microglial marker), but increased expression of Olig2 (an oligodendrocyte marker) assessed by immunofluorescence. Finally, expression of genes related to recruitment of microglia (astrocyte chemokines CXCL10 and CXCL12) and suppression of oligodendrocyte progenitor cell (OPC) differentiation (astrocyte peptides ET-1 and EDNRB) showed a considerable decrease after administration of L-AAA (for all p < 0.05). These results are indicative of improved remyelination after ablation of astrocytes possibly through hampering microgliosis and astrogliosis and a further rise in the number of matured Olig2+ cells. © 2019, Springer Science+Business Media, LLC, part of Springer Nature.
Related Docs
View other Related Docs
1. Combination Therapy of Mesenchymal Stem Cell Transplantation and Astrocyte Ablation Improve Remyelination in a Cuprizone-Induced Demyelination Mouse Model, Molecular Neurobiology (2022)
2. Regulatory Effect of Triiodothyronine on Brain Myelination and Astrogliosis After Cuprizone-Induced Demyelination in Mice, Metabolic Brain Disease (2016)
3. Effect of the Csf1r Inhibitor Plx3397 on Remyelination of Corpus Callosum in a Cuprizone-Induced Demyelination Mouse Model, Journal of Cellular Biochemistry (2019)
4. The Effect of Microglial Ablation and Mesenchymal Stem Cell Transplantation on a Cuprizone-Induced Demyelination Model, Journal of Cellular Physiology (2021)
5. Immunomodulatory Characteristics of Mesenchymal Stem Cells and Their Role in the Treatment of Multiple Sclerosis, Cellular Immunology (2015)
6. The Effects of Mesenchymal Stem Cells Transplantation on A1 Neurotoxic Reactive Astrocyte and Demyelination in the Cuprizone Model, Journal of Molecular Histology (2022)
7. Effect of Mesenchymal Stem Cells on Glial Cells Population in Cuprizone Induced Demyelination Model, Neuropeptides (2019)
8. Intranasal Delivery of Sdf-1Α-Preconditioned Bone Marrow Mesenchymal Cells Improves Remyelination in the Cuprizone-Induced Mouse Model of Multiple Sclerosis, Cell Biology International (2020)
Experts (# of related papers)
View all Related Experts
Iraj Ragerdi Kashani (12)
Parichehr Pasbakhsh (9)
Other Related Docs
9. Mesenchymal Stem Cells Ameliorate Cuprizone-Induced Demyelination by Targeting Oxidative Stress and Mitochondrial Dysfunction, Cellular and Molecular Neurobiology (2021)
10. Effect of Csf1r Inhibitor on Glial Cells Population and Remyelination in the Cuprizone Model, Neuropeptides (2021)
11. Metformin Therapy Attenuates Pro-Inflammatory Microglia by Inhibiting Nf-Κb in Cuprizone Demyelinating Mouse Model of Multiple Sclerosis, Neurotoxicity Research (2021)
12. 17Β-Estradiol Reduces Demyelination in Cuprizone-Fed Mice by Promoting M2 Microglia Polarity and Regulating Nlrp3 Inflammasome, Neuroscience (2021)
13. Low, But Not High, Dose Triptolide Controls Neuroinflammation and Improves Behavioral Deficits in Toxic Model of Multiple Sclerosis by Dampening of Nf-Κb Activation and Acceleration of Intrinsic Myelin Repair, Toxicology and Applied Pharmacology (2018)
14. Stem Cell Therapy ‒Approach for Multiple Sclerosis Treatment, Archives of Neuroscience (2016)
15. The Regenerative Potential of Glial Progenitor Cells and Reactive Astrocytes in Cns Injuries, Neuroscience and Biobehavioral Reviews (2022)
16. A Comprehensive Review on the Treatment Approaches of Multiple Sclerosis: Currently and in the Future, Inflammation Research (2019)
17. Therapeutic Potential of Stem Cells for Treatment of Neurodegenerative Diseases, Biotechnology Letters (2020)
18. Protective Features of Calorie Restriction on Cuprizone-Induced Demyelination Via Modulating Microglial Phenotype, Journal of Chemical Neuroanatomy (2021)